/

Società

AM

Società

AMSBIOPHARMA

Di cosa scriviamo

Auto/AutomotiveFarmaciaSaluteSanitàUniversità

32 comunicati stampa

Guarda tutti i comunicati

Press Release cover image

26/02/2026

Salute

Sanità

Gene and cell therapy analytical strategies and compliance | AMSbiopharma

Fonte

1.00

0

Press Release cover image

19/02/2026

Salute

Farmacia

Sanità

EMA nitrosamines update and acceptable intake limits | AMSbiopharma

Fonte

1.00

0

Press Release cover image

05/02/2026

Salute

Sanità

Fit-for-purpose QC protocols for nucleic acid therapeutics | AMSbiopharma

Fonte

1.00

0

Press Release cover image

03/02/2026

Università

Salute

Sanità

How analytical CROs empower biotech innovation | AMSbiopharma

Fonte

1.00

0

Press Release cover image

18/12/2025

Salute

Sanità

UPLC-MS/MS method development for peptide analysis | AMSbiopharma

Fonte

1.00

0

Press Release cover image

11/12/2025

Salute

Sanità

Stability-indicating methods for peptide drug analysis | AMSbiopharma

Fonte

1.00

0

Press Release cover image

26/11/2025

Salute

Sanità

Accelerate Drug Development with Preclinical Contract Research | AMSbiopharma

Fonte

1.00

0

Press Release cover image

19/11/2025

Università

Salute

Sanità

Optimize LC‑MS/MS Sensitivity: Ion Suppression in Bioanalysis | AMSbiopharma

Fonte

1.00

0

Press Release cover image

29/10/2025

Salute

Sanità

Biomarkers for Bioanalytical Research in Drug Development | AMSbiopharma

Fonte

1.00

0

Press Release cover image

21/10/2025

Università

Salute

Sanità

How Mass Spectrometry enhances GMP quality control with LC‑MS | AMSbiopharma

Fonte

1.00

0

Seguaci

0

Compatibilità

0